Characterization of the MDSC Proteome in Metastatic Breast Cancer
Author Information
Author(s): Angela M. Boutté, W. Hayes McDonald, Yu Shyr, Charles P. Lin
Primary Institution: Vanderbilt University Medical Center
Hypothesis
The study aims to characterize the MDSC proteome in response to metastatic and non-metastatic mammary tumors.
Conclusion
The study identifies distinct protein expression patterns in MDSCs associated with metastatic tumors, suggesting potential biomarkers and therapeutic targets.
Supporting Evidence
- The study identified 2825 protein groups with a low false discovery rate.
- Unique proteins were found in both metastatic and non-metastatic MDSCs.
- Proteins involved in glutathione metabolism were significantly expressed in metastatic MDSCs.
- Distinct biological processes were associated with MDSCs from metastatic tumors.
Takeaway
The study looks at special cells in the body that help tumors grow and spread, finding that these cells behave differently when the tumor is more aggressive.
Methodology
The study used label-free mass spectrometry and shotgun proteomics to analyze MDSCs from mice with different types of mammary tumors.
Limitations
The study is limited to a mouse model and may not fully represent human conditions.
Participant Demographics
Female Balb/c mice aged 6–7 weeks were used in the study.
Statistical Information
P-Value
0.78%
Confidence Interval
99.3% - 99.8%
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website